Neurofibromatosis

Neurofibromatosis is a genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called acoustic neurofibromatosis and NF2.

Overview

Feature Articles

Latest Neurofibromatosis News and Research

Researchers identify a compound that inhibits growth of schwannomas

Researchers identify a compound that inhibits growth of schwannomas

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Mouse orthotopic model was used to determine personalized therapy for relapse sarcoma

Mouse orthotopic model was used to determine personalized therapy for relapse sarcoma

Study identifies common characteristics of pediatric vestibular schwannomas

Study identifies common characteristics of pediatric vestibular schwannomas

Study suggests new ways to fight aggressive brain cancer

Study suggests new ways to fight aggressive brain cancer

Study analyzes cancer diagnosis in children with birth defects

Study analyzes cancer diagnosis in children with birth defects

Study finds potential new therapeutic targets for childhood brain tumors

Study finds potential new therapeutic targets for childhood brain tumors

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Mapping genetic links between diseases using data from electronic health records

Mapping genetic links between diseases using data from electronic health records

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Researchers uncover novel molecular clues for tumor aggression in neurofibromatosis type 1

Researchers uncover novel molecular clues for tumor aggression in neurofibromatosis type 1

New grants support research on mechanics of tumor cells

New grants support research on mechanics of tumor cells

Children's Tumor Foundation harnesses interest in rare disease research through NF Innovation Week

Children's Tumor Foundation harnesses interest in rare disease research through NF Innovation Week

Researchers open up possible avenue for new cancer treatments without side effects

Researchers open up possible avenue for new cancer treatments without side effects

Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Children's Tumor Foundation establishes significant research initiative to combat NF2

Children's Tumor Foundation establishes significant research initiative to combat NF2

Study discovers origin of neurofibromas that develop throughout the skin of NF1 patients

Study discovers origin of neurofibromas that develop throughout the skin of NF1 patients

Research into cancer signaling network reveals new roadmap to tumor control

Research into cancer signaling network reveals new roadmap to tumor control